because considerable cytotoxicity was demonstrated in vitro by 125i-t101 on t65-positive malignant cells , and because low-dose 111in-t101 can be used successfully for tumor localization , future trials using 125i-t101 at high specific radioactivity may improve therapeutic results in patients with t65-positive malignancies .
C0027651
tumor
C0006826
malignancies